Total Visits

Views
Maintenance bacillus Calmette-Guerin immunotherapy for TaG3 or T1G3 and/or carcinoma in situ transitional cell carcinoma of the bladder: Final results of the randomized CUETO Group Study 9801318

Select a period of time:

Number of views in the range

Views

Top country views

Views
 

Top cities views

Views